RxDoctor Payments Data

Brian Galinat, MD

Orthopaedic Surgery · Wilmington, DENPI 1366481350

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (29.7%), consulting fees and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Catalyst Orthoscience at 33.8% of the total.

$13,446in general payments, 2019–2025

Across 41 payments — averaging $327.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Catalyst Orthoscience$5K
  • Biedermann Motech, Inc.$4K
  • Arthrex$3K
  • Liberty Surgical Inc.$1K
  • Stryker$343
  • Davol Inc.$128
  • plus $201 from 5 others

What the payments were for

  • Consulting fees$3,51426%
  • Speaking & faculty fees$4,00030%
  • Travel & lodging$1,2249%
  • Food & beverage$1,2609%
  • Education$3,44726%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Catalyst Orthoscience9$4,546
Biedermann Motech, Inc.1$4,000
Arthrex12$2,907
Liberty Surgical Inc.2$1,321
Stryker(2 entities)7$343
Davol Inc.2$128
Zimmer Biomet2$74
Johnson & Johnson2$44
Medacta USA, Inc.1$34
Pacira Therapeutics, Inc.2$32
Eclipse Technology Solutions Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,446 in reported general payments places this provider in the 65th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$372,535
Medicare patients
753
Services billed
4,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam144$683
Celecoxib23$612
Tramadol Hcl82$271
Amoxicillin60$131
Oxycodone Hcl32$101

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →